You are here: Industry Insights > CytoSorb

News List

CytoSorbents Announces Publication of U.S. CTC Multicenter Registry Results Using CytoSorb® in Critically Ill COVID-19 Patients on Extracorporeal Membrane Oxygenation (ECMO) prnewswire
December 21, 2021
CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification via its proprietary polymer adsorption technology...
CytoSorbents Announces Approval of CytoSorb® in Korea in Collaboration with Partner Fresenius Medical Care prnasia
January 21, 2021
CytoSorbents Corporation, a critical care immunotherapy leader commercializing its CytoSorb® blood purification technology to treat deadly inflammation in critically ill and cardiac surgery patients around the world, announces that the Korean Ministry ...
Health Canada Authorizes CytoSorb for Use in Hospitalized COVID-19 Patients prnewswire
January 05, 2021
CytoSorbents Corporation, a critical care immunotherapy leader commercializing its CytoSorb® blood purification technology to treat deadly inflammation in critically ill and cardiac surgery patients around the world, announces that Health Canada has ...
Biocon Biologics gets DCGI approval for emergency use of CytoSorb to treat critical COVID-19 patient expresspharma
May 28, 2020
Biocon announced that its subsidiary Biocon Biologics has received the Drugs Controller General of India’s (DCGI) approval for an extracorporeal blood purification (EBP) device CytoSorb.
FDA Grants CytoSorb Emergency Use Authorization for COVID-19 Patients americanpharmaceuticalreview
April 15, 2020
CytoSorbents announced the United States Food and Drug Administration (FDA) has granted Emergency Use Authorization (EUA) of CytoSorb® for use in patients with COVID-19 infection.